Plain-English translation of NCT05248763 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are collecting biological samples—including tumor tissue, healthy tissue near the tumor, and blood—from people in Taiwan who have been diagnosed with gastric cancer (stomach cancer). By studying these samples in detail, the team hopes to understand how gastric cancer develops and identify new ways to diagnose it earlier, prevent it, and treat it more effectively.
Gastric cancer is a serious disease with high rates of diagnosis and death in Taiwan. By gathering and analyzing detailed biological information from many patients, researchers hope to create a 'map' of how the disease works, which could lead to personalized treatments tailored to each patient's specific cancer and better ways to catch the disease early.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will provide samples of your tumor tissue, healthy tissue from near the tumor, and blood during a clinical visit. Your medical information will also be collected. The researchers will then analyze these samples in detail to understand your specific cancer. You may be contacted for follow-up information, though specific visit schedules are not detailed in the trial description.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Taiwan
Collaborators
National Taiwan University Hospital
Enrollment target
~4,190 participants
Started
February 2022
Primary completion
December 2026
Age range
20 Years and older
Last updated on clinicaltrials.gov in July 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yu-Ju Chen, PhD
Distinguished Research Fellow
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.